The Bloc Value Builders took home the Gold award for Best Use of Market Access Marketing at the MM+M Awards. A big Thank You to the clients for their unwavering dedication to partnership and collaboration, to the entire Value Builder team for always bringing their best to work every day, to The Bloc for fostering an open and creative environment where ideas can thrive, and thank you to MM+M for putting on such a fantastic event! It was an honor to be chosen among such strong work. Be great to do good and your work will be recognized.
About the awarded work by Novartis and The Bloc Value Builders:
Leqvio and the Advent of Buy-and-Bill in Cardiology.
Cholesterol-reducing Leqvio was projected to be a game-changing treatment for atherosclerotic cardiovascular disease. But prelaunch, it faced strategic and logistical hurdles with payer, provider and office staff audiences. Because the medication would be administered twice yearly in providers’ offices, it required buy-and-bill–naïve cardiologists, PCPs and office staff to use an unfamiliar acquisition pathway.
Its research quickly revealed the need for a large-scale campaign, educating people on these pathways and the buy-and-bill process. And it needed to target subsegments differently, with strategies for integrated delivery networks (IDN), community practices and traditional payers.
About the MM+M Awards:
The objective of the MM+M Awards is to recognize, champion and celebrate creativity and effectiveness in healthcare marketing and communications. An MM+M Award is valued because recognition comes from industry peers.
More than 90 judges boasting a wide variety of expertise narrowed down the hundreds of entries to a select top few. It’s this rigorous analysis that has made the MM+M Awards the industry’s gold standard.
